Back to AIG
AIG Stock: Earnings Beat and Valuation Review
$AIGNEUTRALInsurance—Diversified

AIG Stock: Earnings Beat and Valuation Review

AIG closed at $82.86 on Friday, November 13, after reporting quarterly EPS above analyst estimates. The valuation and price targets suggest limited potential upside, while mixed analyst views and the nature of insurance risks keep the overall picture balanced.

November 14, 202610 min read
Current Price
$82.86
+0.35%
Analyst Rating
Hold
Price Target
$87.63
5.8% upside
P/E Ratio
13.41

Executive Summary

Investment Thesis: AIG combines a recent quarterly earnings beat with a P/E of 13.41 and an analyst target mean above its Friday close. At the same time, the analyst consensus supplied here is Hold, ROE is about 8%, and target estimates differ across data sources. The resulting picture is mixed: operating results and valuation deserve attention, but they do not remove the underwriting, catastrophe, investment-market, and execution risks inherent in a large insurer.

Current Price: $82.86 as of Friday, November 13 | Key Metric: latest reported EPS of $2.06 versus $1.88 estimated | Stance: NEUTRAL

Company Overview

American International Group, Inc. is a global insurance company in the Insurance—Diversified industry. It provides commercial and personal insurance products and services to businesses and individuals. Insurance results depend on pricing, claims, investment income, capital management, and the company’s ability to assess and manage risk across markets.

Key Products & Competitive Position

  • Core Business: Insurance underwriting and related services, with exposure to commercial and personal insurance markets.
  • Key Products: Property and casualty coverage, liability and specialty insurance, and other insurance offerings. Product mix and availability can vary by geography and customer segment.
  • Competitive Moat: AIG’s global brand, established broker and customer relationships, underwriting experience, and scale can support access to complex risks. These advantages are not guarantees of strong underwriting performance or high returns.

Recent Developments

Recent company-related headlines in the supplied news set mainly concern institutional ownership disclosures and third-party stock commentary. Bingham Private Wealth reported a new stake, while Ethic Inc. and Chicago Partners Investment Group reported increases in their AIG holdings. Such filings provide a snapshot of past positions, not evidence of future performance or a change in AIG’s operations. Zacks also published value- and momentum-oriented commentary, which is a third-party style assessment rather than a company announcement.

Financial Snapshot

Market Cap$43.93B
P/E Ratio13.41
52-Week Range$71.25 - $87.29
Dividend Yield2.29%
EPS (TTM)$6.30
ROE8.18%

Revenue & Earnings Trends

AIG reported EPS of $2.06 for the quarter reported November 3, above the supplied analyst estimate of $1.88, a $0.18 or roughly 9.6% beat. That is a favorable data point, but one quarter alone does not establish a durable earnings trend. Supplemental provider data lists revenue growth of 16.4% and earnings growth of 72.0%, but the supplied figures do not identify the comparison period or accounting basis. They should therefore be treated as directional context, not as a complete, audited trend analysis.

Provider data also differs on trailing EPS: the supplied key metrics show $6.30, while the supplemental quote page lists $6.13. The report uses the requested $6.30 figure for the snapshot and notes the discrepancy rather than treating the measures as interchangeable. Insurance revenue and earnings can also be affected by claim timing, catastrophe losses, reserve adjustments, and investment returns.

Balance Sheet Highlights

The supplied figures show a current ratio of 1.36, while supplemental data reports 0.61, alongside a quick ratio of 0.22. These measures may use different reporting dates or definitions. For insurers, conventional current and quick ratios can be less informative than they are for industrial companies because policy liabilities, invested assets, and regulatory capital are central to the business model. The provider lists $11.85 billion of cash and $10.41 billion of debt, as well as debt-to-equity of 26.75%. Those items offer context but are not a substitute for reviewing statutory capital, investment portfolio quality, reserve adequacy, and liquidity by operating entity.

Valuation Analysis

Current Valuation Metrics

Forward P/E9.5vs Industry: comparison unavailable
PEG Ratio0.69Growth-adjusted, provider-reported
EV/EBITDA4.76vs Historical: comparison unavailable
P/S Ratio1.58vs Peers: comparison unavailable

Historical Comparison

The available data does not provide a five-year average P/E, EV/EBITDA, or price-to-book multiple, so a precise historical comparison cannot be made here. At 1.11 times book value and 13.41 times trailing EPS, AIG’s supplied multiples provide a starting point for comparison, but insurers’ book values and earnings can move with market prices, reserve estimates, and catastrophe claims. The supplemental provider’s 4.76 EV/EBITDA and 0.69 PEG are also data-source calculations, and their usefulness depends on consistent definitions and forecasts.

Fair Value Estimate

The supplied analyst mean target of $87.63 is about 5.8% above the $82.86 close, while the median is $88.50. This points to modest implied upside in that particular analyst set, not a guaranteed outcome. A separate quote-page extract reports a mean target of $88.55, a high of $103, and 20 analyst opinions, versus the provided target set’s $98 high and 22 analysts. That divergence matters: target coverage, dates, and methodologies may differ. A useful valuation assessment would also test earnings under higher claims, lower investment income, and weaker pricing assumptions. No single target should be treated as intrinsic value.

Competitive Landscape

Market Position

Market Share: Not provided | Ranking: Not established by the supplied data

Key Competitors

The Travelers Companies (TRV)The Travelers Companies, a large property and casualty insurer with commercial and personal lines.
The Allstate (ALL)The Allstate Corporation, with significant personal lines and property and casualty insurance operations.
$CBChubb Limited, a global insurer competing across commercial and personal insurance markets.

Competitive Advantages

  • Global reach: Operating across markets can support access to multinational customers and a wider range of insurance risks.
  • Underwriting experience: Established data, expertise, and distribution relationships can help evaluate complex commercial exposures and price policies.
  • Scale and recognition: A longstanding brand and broad capabilities can matter to brokers and clients seeking coverage across multiple risks. The value of these advantages depends on consistent underwriting discipline.

Earnings Track Record

Last 4 Quarters: 1 documented beat / 0 documented misses, 3 quarters unavailable

Recent Earnings History

Q3 2026$2.06 vs $1.88 estBEAT
Q2 2026Actual and estimate not suppliedN/A
Q1 2026Actual and estimate not suppliedN/A
Q4 2025Actual and estimate not suppliedN/A

Guidance Trend

The supplied information does not include a full-year earnings outlook, management guidance revisions, or a quantified underwriting target. The next reported earnings date is listed as February 9, 2027, with an EPS estimate of $2.06. That estimate is a market expectation, not company guidance, and may change as analysts incorporate claims experience, investment returns, and updated company disclosures. Watch for commentary on pricing, loss costs, catastrophe exposure, reserves, and capital deployment when results are released.

Analyst Sentiment

Consensus Rating: Hold

Strong Buy: 1 Buy: 7 Hold: 14 Sell: 0 Strong Sell: 0

Price Targets

  • Low: $80
  • Mean: $87.63 (+5.8% implied upside)
  • High: $98

Recent Analyst Actions

UBS maintained a Buy rating and raised its target from $100 to $103 on November 10. Piper Sandler maintained Neutral and raised its target from $84 to $85 on November 9, while Wells Fargo maintained Equal-Weight and raised its target from $83 to $85 on November 5. The target changes are mixed in scale and do not amount to a broad consensus shift. The supplied tally of 22 analysts is Hold overall, while a supplemental quote page shows a different recommendation mean and 20 opinions. These datasets should not be combined as though they were one synchronized survey.

Recent News & Catalysts

Key Developments

  • Quarterly earnings beat: AIG reported EPS of $2.06 against an estimate of $1.88 on November 3. Investors can assess the result alongside underlying underwriting performance and any catastrophe or reserve effects.
  • Institutional ownership filings: Bingham Private Wealth disclosed a newly purchased stake, while Ethic Inc. and Chicago Partners reported increases in holdings. These are historical portfolio disclosures and do not establish the rationale or future intentions of the firms.
  • Third-party style commentary: Zacks published value- and momentum-focused articles on November 11 and November 9. These are screening or style assessments, not confirmed corporate developments or guarantees of future returns.

Upcoming Catalysts

Next Earnings: February 9, 2027, listed expected EPS $2.06 | Key Events: quarterly underwriting results, catastrophe losses, reserve development, investment income, pricing trends, and any capital-management updates

Technical Outlook

Current Price: $82.86 vs 52-Week High: $87.29 (-5.1% from high)

Trend Analysis

AIG’s November 13 close was $0.29, or 0.35%, above the previous close of $82.57. The session range was $82.455 to $83.551. The price sits within the supplied 52-week range of $71.25 to $87.29, roughly 5.1% below the high and 16.3% above the low. These figures describe recent positioning, not a prediction. US markets are closed Saturday, November 14; the next regular trading session is Monday, November 16.

Key Levels

  • Resistance: Around $83.55, the supplied Friday session high, then $87.29, the 52-week high.
  • Support: Around $82 and $80 as nearby reference areas, followed by $71.25, the 52-week low. These are observational levels, not confirmed technical floors.

Bull vs Bear Case

Bull Case

  • Earnings: The latest EPS result exceeded the provided estimate by about 9.6%, which may indicate better-than-expected quarterly performance.
  • Valuation: The 13.41 trailing P/E, 1.11 price-to-book ratio, and provider-reported 9.5 forward P/E offer valuation reference points that some market participants may view as moderate.
  • Analyst targets: The supplied mean target is 5.8% above the Friday close, and UBS recently raised its target while maintaining its rating.

Bull Target: $98, the high in the supplied analyst target set, about 18.3% above $82.86. This is an analyst scenario, not a forecast.

Bear Case

  • Insurance losses: Catastrophe events, elevated claims, or adverse reserve development could pressure underwriting results and earnings.
  • Moderate returns: ROE near 8.2% may constrain the case for a higher valuation if profitability does not improve or capital costs remain significant.
  • Limited target cushion: The $80 low target is below the close, and the consensus is Hold. Price targets also vary between supplied sources, increasing uncertainty around their usefulness.

Bear Target: $80, the low in the supplied analyst target set, about 3.5% below $82.86. This is an analyst scenario, not a forecast.

Risks to Consider

  • Valuation Risk: A low-looking earnings multiple can reflect expectations of cyclical earnings, claim volatility, or lower returns. If earnings estimates weaken, the apparent valuation support may diminish.
  • Competitive Risk: Insurers compete on price, claims service, broker relationships, and product terms. Aggressive pricing can erode margins, while disciplined pricing can cost market share.
  • Macro Risk: Interest rates, credit markets, inflation in repair and medical costs, foreign exchange, and severe weather can affect investment income and claim expenses. Insurers can face both asset and liability pressures at once.
  • Execution Risk: Underwriting quality, reserving judgments, operational changes, and capital allocation require consistent execution. A single earnings beat does not settle questions about longer-term performance.

Bottom Line

Investment Verdict: NEUTRAL

AIG’s latest earnings beat, moderate headline multiples, and analyst target mean above the November 13 close are constructive observations, but the available evidence is not uniformly positive. A Hold consensus, ROE around 8%, gaps in the four-quarter earnings record, and insurance-specific risks support a balanced reading rather than a directional conclusion. This report is informational and is not personalized investment advice.

Action Items for Investors

  • Long-term investors: Track multi-quarter underwriting margins, reserve development, capital strength, and returns on equity rather than relying on one quarterly EPS result or a headline valuation multiple.
  • Short-term traders: Note the Monday, November 16 reopening after the weekend, and monitor the nearby reference levels and broader market conditions. Technical levels can fail and are not a substitute for risk controls.
  • Risk management: Compare analyst estimates with company disclosures, verify financial ratios across consistent sources, and account for event, catastrophe, and portfolio concentration risks in any investment analysis.

What to Watch This Week

  • AIG’s price and volume behavior when US markets reopen Monday, November 16, noting that the Friday session closed at $82.86.
  • Any company disclosures or insurance-industry developments that offer new information on pricing, claims, catastrophe losses, or investment conditions.
  • Changes in analyst estimates or targets, while keeping the conflicting target datasets and the February 9, 2027 earnings date in view.

Share this report

Share this article

Spread the word on social media

Think AIG will outperform? Prove it.

Free practice contests — earn Alpha Coins
Enter a Contest

Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.

Spotted something wrong? Report an error.